Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abbreviated, aberrant, absorbing, abundant, Adial, Anktiva, annuity, art, backbone, baseline, binding, Bio, Cary, central, CEO, chair, chairperson, chemotherapy, chemotoxic, chemotoxin, circumvent, Claiborne, CNS, collaborating, concept, Cooperation, CR, DCR, deal, declassification, declassify, Denmark, DGCL, dissuade, distraction, documentary, DoR, durability, Eastern, enjoy, entry, excellent, Foundation, Francisco, Genentech, GMP, groundwork, Hammann, hamper, Immunity, immunotherapy, implied, Indivior, inflationary, inflection, inter, inventoried, inventorship, Jerald, KemPharm, ladrx, LADX, licensor, maintenance, marker, maytansine, meaningful, MedicAlert, moved, NACD, native, NeuroSense, nonqualified, nutritional, ORR, OS, parallel, plasma, PLC, precatory, procedural, Prosperity, protein, proven, provoke, purported, put, quantify, QUILT, RECIST, reinstatement, reinterpreted, run, Seagen, secrecy, shortly, signaling, Sucampo, territory, therewith, turn, undo, valuable, vascular, Villanova, wrongfully, Zevra
Removed:
accumulation, agree, antibody, applicability, assist, assistant, assume, Belzer, biology, blood, bloodstream, Breakthrough, breast, Brien, bypassing, Columbia, combining, concentrate, concentration, conjugated, controlling, cytotoxin, CYTR, dean, delivery, Distinguished, engine, esteemed, excise, exercisability, fluctuate, head, highlighted, hydrazine, importance, indemnification, indemnified, indemnify, Jerome, Laureate, liaison, medicine, Minnesota, molecule, neck, Nobel, personalized, Pharmacology, pharmacy, Prize, professor, reemployment, reliably, repay, researcher, separate, size, successive, successor, suit, systemic, toolbox, tract, UCLA, unissued, USD, version, withholding
Filing tables
Filing exhibits
LADX similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
LadRx Corporation
Los Angeles, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-258453), Form S-3 (File Nos. 333-255431, 333-223808, 333-208803 and 333-215252) and Form S-8 (File Nos. 333-249624, 333-68200, 333-93305, 333-123339, 333-163212 and 333-212934) of LadRx Corporation of our report dated March 20, 2023, relating to the consolidated financial statements for the years ended December 31, 2022 and 2021 (modified for a going concern uncertainty), which appears in this Form 10-K.
/s/ Weinberg & Company
Los Angeles, California
March 20, 2023